AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 21936956
Drug: Weekly low
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Weekly low dose zoledronic acid
Trial: 3087915
Drug: Combined oral
RxNorm normalized name: combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined oral contraceptives (30 or 50 micrograms ethinyl oestradiol and 150 micrograms levonorgestrel)
Trial: 20655766
Drug: Intra-articular corticosteroid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intra-articular corticosteroid injection (accuracy identified by fluoroscopy)
Trial: 10680784
Drug: Lidocaine (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lidocaine (5 mg/kg IV over 30 minutes)
Trial: 9292253
Drug: Various treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Various treatment options that block calcium channels or inhibit the sodium-mediated calcium transporter to prevent axonal damage.
Trial: 3535364
Drug: Intracervical PGE2‐gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intracervical PGE2‐gel twice with a 12‐hour interval
Trial: 3535364
Drug: Intracervical placebo
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intracervical placebo gel twice with 12‐hour interval
Trial: 20375907
Drug: Experimental treatments
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Experimental treatments (BP-lowering agents)
Trial: 17985242
Drug: Intravenous pantoprazole
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous pantoprazole 80 mg loading dose over 5 min, followed by 8 mg/h intravenous infusion for 72 h, then 40 mg orally once a day for 4 days.
Trial: 17985242
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group received 40 mg pantoprazole intravenously once a day for 72 h, then orally once a day for 4 days.
Trial: 16021478
Drug: Acupuncture plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acupuncture plus antiemetic medication
Trial: 16021478
Drug: Anti-emetic medication
RxNorm normalized name: pramoxine hydrochloride Medicated Pad [Scalpicin Anti-Itch]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Anti-emetic medication alone
Trial: 10894441
Drug: Amlodipine (monotherapy)
DrugBank: Amlodipine (DB00381)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Amlodipine (monotherapy)
Trial: 6293715
Drug: Cefotaxime (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cefotaxime (20 mg/kg every six hours)
Trial: 6293715
Drug: Gentamicin (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gentamicin (1 mg/kg every eight hours) plus Clindamycin (5 mg/kg every six hours)
Trial: 30928863
Drug: 100 mg
RxNorm normalized name: urea 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg quetiapine daily for 8 weeks
Trial: 25925036
Drug: Interscalene brachial
RxNorm normalized name: Brachiara mutica pollen
DrugBank: Urochloa mutica pollen (DB10716)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Interscalene brachial plexus block (ISPB) with 20 mL 0.25% bupivacaine
Trial: 25925036
Drug: Intra-articular (IA)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intra-articular (IA) administration with 20 mL 0.25% bupivacaine
Trial: 23106905
Drug: Dual antiplatelet
RxNorm normalized name: Tums Dual Action
DrugBank: Alginic acid (DB13518)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dual antiplatelet therapy (DAT; aspirin and prasugrel)
Trial: 23106905
Drug: Triple antiplatelet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Triple antiplatelet therapy (TAT; aspirin, clopidogrel, cilostazol)
Trial: 21798863
Drug: 2 ×
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 × 25 g/day whey protein (PRO)
Trial: 19326422
Drug: Intrathecal morphine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intrathecal morphine (400 microg) combined with intravenous patient-controlled analgesia (IV-PCA)
Trial: 26689781
Drug: Intravenous patient-controlled
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous patient-controlled analgesia (IV-PCA) alone
Trial: 28844213
Drug: R. ribes
FDA approved: no
EMA approved: no
PMDA approved: no
Description: R. ribes syrup
Trial: 12521274
Drug: Oxygen mask
RxNorm normalized name: oxygen masks
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oxygen mask treatment
Trial: 8339132
Drug: 100 mg/day
RxNorm normalized name: infigratinib phosphate 100 mg/day (100 mg x 1) ORAL CAPSULE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg/day of slow release diclofenac
Trial: 3549420
Drug: Trazodone (100-150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Trazodone (100-150 mg/day)
Trial: 12111446
Drug: Cerebrolysin (Cere),
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cerebrolysin (Cere), 30 mL injected intravenously, five days per week for four weeks
Trial: 11874388
Drug: mizolastine 10
RxNorm normalized name: mizolastine 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: mizolastine 10 mg
Trial: 2012082
Drug: 5 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 mg aerosol pentamidine biweekly
Trial: 2012082
Drug: 60 mg
RxNorm normalized name: opium 60 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 60 mg aerosol pentamidine biweekly
Trial: 2012082
Drug: 120 mg
RxNorm normalized name: papain 120 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 120 mg aerosol pentamidine biweekly
Trial: 7084029
Drug: Trimethoprim/sulfamethoxazole (TMP/SMX)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Trimethoprim/sulfamethoxazole (TMP/SMX) 6.8/34 mg/kg/d divided into twice daily doses for six months
Trial: 7084029
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (acute treatment only)
Trial: 27693866
Drug: Other stimulant
RxNorm normalized name: Ether
DrugBank: Diethyl ether (DB13598)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Other stimulant use disorder
Trial: 11270805
Drug: amoxicillin/clavulanic acid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: amoxicillin/clavulanic acid Solutab tablet (500/125)
Trial: 11270805
Drug: amoxicillin/clavulanic acid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: amoxicillin/clavulanic acid Solutab tablet (500/125) after excluding outliers
Trial: 11270805
Drug: Augmentan film‐coated
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Augmentan film‐coated tablet (reference)
Trial: 11270805
Drug: amoxicillin/clavulanic acid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: amoxicillin/clavulanic acid Solutab tablet (intact or dispersed)
Trial: 21809439
Drug: Light roast
RxNorm normalized name: Coffea arabica seed, roasted
DrugBank: Coffea arabica seed, roasted (DB15603)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Light roast coffee (CGA: 4538 μmol/L, NMP: 56 μmol/L)
Trial: 14593691
Drug: Immediate multi-family
RxNorm normalized name: Parasedge Multi
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Immediate multi-family psychoeducation groups (MFPG) plus treatment as usual
Trial: 11069436
Drug: New-users of
FDA approved: no
EMA approved: no
PMDA approved: no
Description: New-users of the drug
Trial: 11069436
Drug: Drug epidemiology
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Drug epidemiology
Trial: 8755685
Drug: Enalapril 20
RxNorm normalized name: enalapril 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enalapril 20 mg/d (increased to 40 mg/d if inadequate response)
Trial: 8755685
Drug: Enalapril 20
RxNorm normalized name: enalapril 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enalapril 20 mg + indomethacin 75 mg/d
Trial: 2163421
Drug: Captopril 25
RxNorm normalized name: captopril 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Captopril 25 mg twice a day
Trial: 25234550
Drug: Reference tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Reference tablet
Trial: 29678772
Drug: High dose
RxNorm normalized name: INFLUENZA VACCINE HIGH DOSE 0.5ML SYR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High dose minocycline (200 mg per day)
Trial: 17221013
Drug: Intravenous metoclopramide
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous metoclopramide
Trial: 28338180
Drug: Dezocine (0.1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dezocine (0.1 mg/kg in 20 ml infused for 10 min)
Trial: 24167370
Drug: 2-dose series
RxNorm normalized name: triclosan
DrugBank: Triclosan (DB08604)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 2-dose series of nonadjuvated monovalent influenza A H1N1 2009 vaccine
Trial: 26041682
Drug: ESRA‐C intervention
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ESRA‐C intervention delivered via the Internet or tablet at the clinic
Trial: 21430075
Drug: 30 mg/d
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30 mg/d of lycopene as a tomato oleoresin for 21 days
Trial: 9728734
Drug: 1.0 mg
RxNorm normalized name: HYDROCORTISONE BUTYRATE 1.0 mg in 1 g TOPICAL CREAM
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.0 mg flunitrazepam
Trial: 7994508
Drug: Clonidine (0.2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clonidine (0.2 mg daily to 1.2 mg daily over 14 days)
Trial: 7994508
Drug: Dummy medication
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dummy medication (placebo)
Trial: 28266963
Drug: TV-45070 ointment
RxNorm normalized name: Tv-3326 free base
DrugBank: Ladostigil (DB16213)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TV-45070 ointment
Trial: 28266963
Drug: TV-45070 ointment
RxNorm normalized name: Tv-3326 free base
DrugBank: Ladostigil (DB16213)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TV-45070 ointment in patients with R1150W polymorphism
Trial: 28266963
Drug: TV-45070 ointment
RxNorm normalized name: Tv-3326 free base
DrugBank: Ladostigil (DB16213)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TV-45070 ointment in wild-type carriers
Trial: 10785225
Drug: Flutamide (250
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Flutamide (250 mg/d)
Trial: 2952426
Drug: Guar bread
RxNorm normalized name: Guar Gum
DrugBank: Guar gum (DB13446)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Guar bread (100 g guar/kg wheat flour)
Trial: 2952426
Drug: Guar granulate
RxNorm normalized name: Guar Gum
DrugBank: Guar gum (DB13446)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Guar granulate (5 g twice daily providing 8.3 g guar/day)
Trial: 1894930
Drug: Edoxudine 3%
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Edoxudine 3% cream for 5 days
Trial: 31521449
Drug: Oral melatonin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral melatonin
Trial: 21034626
Drug: Anti-oxidants group
RxNorm normalized name: Anti Bac
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Anti-oxidants group (vitamin C, vitamin E, Salvia Miltiorrhiza L)
Trial: 16181530
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no medicine)
Trial: 9350363
Drug: Bupivacaine 0.5%
RxNorm normalized name: BUPivacaine 0.5% injectable kit
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bupivacaine 0.5% plain (2 mg.kg‐1) - Wound infiltration (Group A)
Trial: 9350363
Drug: Bupivacaine 0.5%
RxNorm normalized name: BUPivacaine 0.5% injectable kit
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bupivacaine 0.5% plain (2 mg.kg‐1) - Regional nerve blockade (Group B)
Trial: 9350363
Drug: Bupivacaine 0.5%
RxNorm normalized name: BUPivacaine 0.5% injectable kit
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bupivacaine 0.5% plain (2 mg.kg‐1) - Combination of wound infiltration and regional nerve blockade (Group C)
Trial: 30290765
Drug: Modified Robert
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Modified Robert Jones bandage (MRJB) compression therapy for 24 hours
Trial: 30290765
Drug: No compression
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No compression therapy (Control)
Trial: 27237764
Drug: mSMT treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: mSMT treatment
Trial: 24501162
Drug: 100 mg/day
RxNorm normalized name: infigratinib phosphate 100 mg/day (100 mg x 1) ORAL CAPSULE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg/day saffron
Trial: 20004276
Drug: 1.0 mg
RxNorm normalized name: HYDROCORTISONE BUTYRATE 1.0 mg in 1 g TOPICAL CREAM
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.0 mg intraamniotic (1.0 IA)
Trial: 20004276
Drug: 1.0 mg
RxNorm normalized name: HYDROCORTISONE BUTYRATE 1.0 mg in 1 g TOPICAL CREAM
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.0 mg intrafetal (1.0 IF)
Trial: 20004276
Drug: 1.5 mg
RxNorm normalized name: boron 1.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.5 mg intraamniotic (1.5 IA)
Trial: 20004276
Drug: 1.5 mg
RxNorm normalized name: boron 1.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.5 mg intrafetal (1.5 IF)
Trial: 12832959
Drug: Abstinence with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Abstinence with transdermal nicotine patch (25 mg per day)
Trial: 20347467
Drug: Abstinence with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Abstinence with placebo patch
Trial: 8849265
Drug: Subcutaneous rhG‐CSF
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subcutaneous rhG‐CSF (lenograstim, 2 micrograms per kg of body weight per day)
Trial: 1462489
Drug: Vaginally administered
RxNorm normalized name: no vaccine administered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vaginally administered estriol at a dose of 0.01 g daily for 3 weeks, and 0.01 g bi‐weekly for a further 3 weeks
Trial: 1462489
Drug: Vaginally administered
RxNorm normalized name: no vaccine administered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vaginally administered estriol
Trial: 30326906
Drug: Self-management exercise
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Self-management exercise program + spa therapy (5 sessions of self-management exercise, 18 sessions of spa therapy)
Trial: 30326906
Drug: Information booklet
RxNorm normalized name: Inflammation OTC Bruise
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Information booklet + spa therapy (18 sessions of spa therapy)
Trial: 30326906
Drug: Self-management exercise
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Self-management exercise program + spa therapy
Trial: 22569484
Drug: 60 μg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 60 μg vaccine
Trial: 22569484
Drug: 120 μg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 120 μg vaccine
Trial: 22569484
Drug: 200 μg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 μg vaccine
Trial: 20353751
Drug: Test formulation
RxNorm normalized name: mumps skin test antigen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Test formulation (20 mg leflunomide)
Trial: 18300351
Drug: Treatment of
RxNorm normalized name: DRUGS FOR TREATMENT OF LEPRA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment of H pylori-positive patients and all H pylori-positive family members (group I)
Trial: 12566476
Drug: Protein Group
RxNorm normalized name: protein C
DrugBank: Protein C (DB11312)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Protein Group consuming a diet with a CHO/protein ratio of 1.4 (125 g protein/d)
Trial: 9346692
Drug: Control interval
RxNorm normalized name: Minerval
DrugBank: Idroxioleic acid (DB18213)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control interval (no drug)
Trial: 1678797
Drug: Multimodal therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Multimodal therapy (laxatives plus behaviour modification)
Trial: 27825009
Drug: Anakinra (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Anakinra (2 mg/kg per day, up to 100 mg for 2 months)
Trial: 24188873
Drug: Long GnRH
RxNorm normalized name: long pepper extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Long GnRH agonist
Trial: 24188873
Drug: Short GnRH
RxNorm normalized name: short ragweed pollen extract Sublingual Tablet [Ragwitek]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Short GnRH agonist
Trial: 9398894
Drug: Omeprazole 20
RxNorm normalized name: omeprazole 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Omeprazole 20 mg + Metronidazole 400 mg + Clarithromycin 500 mg (OMC500)
Trial: 9398894
Drug: Omeprazole 20
RxNorm normalized name: omeprazole 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Omeprazole 20 mg + Amoxicillin 1 gm + Clarithromycin 250 mg (OAC250)
Trial: 9398894
Drug: Omeprazole 20
RxNorm normalized name: omeprazole 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Omeprazole 20 mg + Amoxicillin 1 gm + Metronidazole 400 mg (OAM)
Trial: 9398894
Drug: Omeprazole 20
RxNorm normalized name: omeprazole 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Omeprazole 20 mg + Placebo (OP)
Trial: 3872061
Drug: Casein hydrolysate
RxNorm normalized name: casein hydrolysate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Casein hydrolysate preparation
Trial: 3872061
Drug: Higher protein
RxNorm normalized name: protein C
DrugBank: Protein C (DB11312)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Higher protein intake formulas (4.3 g/kg/day and 4.4 g/kg/day)
Trial: 24062326
Drug: Fixed meal
RxNorm normalized name: bone meal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fixed meal dosing
Trial: 24062326
Drug: Flexible meal
RxNorm normalized name: bone meal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Flexible meal dosing
Trial: 22029980
Drug: Briakinumab (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Briakinumab (200 mg at weeks 0 and 4, 100 mg at week 8 and every 4 weeks thereafter)
Trial: 22029980
Drug: Methotrexate (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methotrexate (5 to 25 mg weekly)
Trial: 16937305
Drug: Concurrent cisplatin
RxNorm normalized name: Cisplatin
DrugBank: Cisplatin (DB00515)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Concurrent cisplatin (CDDP) at 50 mg/m(2) for monthly schedule
Trial: 11598313
Drug: Clioquinol 20
RxNorm normalized name: Clioquinol
DrugBank: Clioquinol (DB04815)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Clioquinol 20 mg/day
Trial: 11598313
Drug: Clioquinol 80
RxNorm normalized name: Clioquinol
DrugBank: Clioquinol (DB04815)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Clioquinol 80 mg/day
Trial: 9531122
Drug: Continuous-flow cold
RxNorm normalized name: Ivy Dry Super Continuous Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous-flow cold therapy for 3 days, then as needed for days 4-7.
Trial: 7758059
Drug: Diclofenac dispersible
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diclofenac dispersible 50 mg
Trial: 2783753
Drug: Predonation of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Predonation of autologous blood and isovolumetric substitution of hydroxyethyl starch (10 ml/kg bodyweight) after induction of anesthesia plus cell separator (Group III)
Trial: 12518131
Drug: No rectal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No rectal tube insertion
Trial: 12929752
Drug: Intraoperative photodynamic
RxNorm normalized name: Sensitizers used in photodynamic/radiation therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intraoperative photodynamic therapy (PDT)
Trial: 31605493
Drug: Daily doses
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily doses of rhEPO combined with iron supplement starting 3 days before surgery (Group A)
Trial: 29095982
Drug: 40 U
RxNorm normalized name: lipase 10440 UNT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 40 U insulin spray
Trial: 29095982
Drug: 80 U
RxNorm normalized name: lipase 20880 UNT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 80 U insulin spray
Trial: 21041815
Drug: 1 L
RxNorm normalized name: BLUE 1 LAKE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 L of clear apple juice
Trial: 21041815
Drug: 1 L
RxNorm normalized name: BLUE 1 LAKE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 L of clear apple juice without polyphenols (placebo)
Trial: 21041815
Drug: 1 L
RxNorm normalized name: BLUE 1 LAKE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 L of cloudy apple juice (positive control)
Trial: 18846024
Drug: Orlistat (120
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Orlistat (120 mg, single dose)
Trial: 16248381
Drug: Technetium‐99m DTPA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Technetium‐99m DTPA aerosol inhalation scintigraphy
Trial: 8580273
Drug: Erythromycin 500
RxNorm normalized name: erythromycin 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Erythromycin 500 mg
Trial: 18435833
Drug: Erythromycin 250
RxNorm normalized name: erythromycin 250 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Erythromycin 250 mg
Trial: 28351201
Drug: Active electroconvulsive
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Active electroconvulsive therapy
Trial: 28351201
Drug: Sham electroconvulsive
RxNorm normalized name: BLACK BEAN ANTI HAIR LOSS SHAM POO SET KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sham electroconvulsive therapy
Trial: 20652288
Drug: 400 μg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 400 μg oral misoprostol
Trial: 20652288
Drug: 400 μg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 400 μg sublingual misoprostol
Trial: 20298399
Drug: Medication alone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Medication alone (salmeterol/fluticasone propionate)
Trial: 16621879
Drug: Torasemide (4‐8
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Torasemide (4‐8 mg/day; n = 20)
Trial: 16621879
Drug: Furosemide (20‐40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Furosemide (20‐40 mg/day; n = 20)
Trial: 10360914
Drug: Control cycle
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control cycle (before treatment)
Trial: 1937993
Drug: Adalat (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adalat (10 mg capsules)
Trial: 1937993
Drug: Nifecard (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nifecard (10 mg capsules)